{"id":1852,"date":"2025-05-02T10:00:00","date_gmt":"2025-05-02T02:00:00","guid":{"rendered":"https:\/\/diosmin-hesperidin.com\/?p=1852"},"modified":"2025-05-06T16:03:37","modified_gmt":"2025-05-06T08:03:37","slug":"in-depth-analysis-of-the-combination-of-diosmin-and-hesperidin","status":"publish","type":"post","link":"https:\/\/diosmin-hesperidin.com\/?p=1852","title":{"rendered":"In-depth analysis of the combination of Diosmin and Hesperidin"},"content":{"rendered":"\n<p>1. Advantages of the combination: Multi-target synergy, enhanced effect<\/p>\n\n\n\n<p>Improvement of venous tone and microcirculation<\/p>\n\n\n\n<p>Diosmin directly enhances venous tone by prolonging norepinephrine-induced venoconstriction, while hesperidin stabilizes the vascular endothelium and reduces capillary leakage through antioxidant action. Both synergistically improve venous elasticity and microcirculatory blood flow.<\/p>\n\n\n\n<p>Superimposed effect of anti-inflammation and anti-edema<\/p>\n\n\n\n<p>Diosmin inhibits the adhesion of leukocytes to endothelial cells and reduces the release of inflammatory mediators (e.g. histamine, prostaglandins); Hesperidin further enhances the anti-inflammatory effect by inhibiting the inflammatory signaling pathway (e.g. TNF-\u03b1, IL-6). The combination treatment has been clinically shown to significantly reduce swelling and pain during acute hemorrhoidal flare-ups.<\/p>\n\n\n\n<p>Micronized formulations enhance efficacy<\/p>\n\n\n\n<p>Micronization technology increases the contact area between the drug and the small intestine by 20 times, improves the absorption rate by 4 times, has a faster onset of action (1 hour), and enhances the therapeutic effect by more than 30%.<\/p>\n\n\n\n<p>2. Clinical application: wide range of indications and sufficient evidence<\/p>\n\n\n\n<p>Core indications<\/p>\n\n\n\n<p>Chronic venous insufficiency: improve lower limb heaviness, pain, edema, and promote healing of venous ulcers.<\/p>\n\n\n\n<p>Hemorrhoids: shorten the acute flare-up period and reduce the frequency of recurrence.<\/p>\n\n\n\n<p>Varicose veins: relieve leg soreness and earthworm-like bulging of blood vessels.<\/p>\n\n\n\n<p>Expanded Applications<\/p>\n\n\n\n<p>Diabetic microangiopathy: improve retinopathy and neuropathy.<\/p>\n\n\n\n<p>Lymphedema: e.g., postoperative upper extremity edema after breast cancer requiring long-term medication (&gt;6 months).<\/p>\n\n\n\n<p>Thrombosis prophylaxis: preoperative and postoperative combination of low molecular heparin to reduce the risk of thrombosis.<\/p>\n\n\n\n<p>Practical examples<\/p>\n\n\n\n<p>Prescription use in Europe: as a multinational prescription drug for the first-line treatment of venous disease and hemorrhoids.<\/p>\n\n\n\n<p>Supported by clinical studies: e.g. Daflon (Diosmin\/Hesperidin) significantly improves symptoms of chronic venous insufficiency and promotes ulcer healing.<\/p>\n\n\n\n<p>3. Comparison with other therapies: Balance of safety and compliance<\/p>\n\n\n\n<p>vs. Surgery<\/p>\n\n\n\n<p>Advantages: Non-invasive, no trauma and no risk of infection.<\/p>\n\n\n\n<p>vs. other drugs<\/p>\n\n\n\n<p>Advantage: The combination is more comprehensive in terms of anti-inflammatory and antioxidant properties than a single ingredient (e.g., pure deoxynivalenol).<\/p>\n\n\n\n<p>Low incidence of side effects (e.g., gastrointestinal reactions are only rare) and well tolerated in the long term.<\/p>\n\n\n\n<p>vs. Lifestyle interventions<\/p>\n\n\n\n<p>Advantage: rapid symptomatic relief, especially suitable for acute exacerbation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1. Advantages of the combination: Multi-target synergy, enhanced effect Improvement of venous tone and microcirculation Diosmin directly enhances venous tone by prolonging norepinephrine-induced venoconstriction, while hesperidin stabilizes the vascular endothelium and reduces capillary leakage through antioxidant action. Both synergistically improve venous elasticity and microcirculatory blood flow. Superimposed effect of anti-inflammation and anti-edema Diosmin inhibits the [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":1853,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1852","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry-news"],"_links":{"self":[{"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=\/wp\/v2\/posts\/1852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1852"}],"version-history":[{"count":1,"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=\/wp\/v2\/posts\/1852\/revisions"}],"predecessor-version":[{"id":1854,"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=\/wp\/v2\/posts\/1852\/revisions\/1854"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=\/wp\/v2\/media\/1853"}],"wp:attachment":[{"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diosmin-hesperidin.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}